Your browser is no longer supported. Please, upgrade your browser.
MNKD MannKind Corporation daily Stock Chart
MannKind Corporation
Index- P/E- EPS (ttm)-1.12 Insider Own0.10% Shs Outstand122.68M Perf Week-4.41%
Market Cap318.97M Forward P/E- EPS next Y-0.73 Insider Trans174.80% Shs Float110.00M Perf Month-19.00%
Income-117.30M PEG- EPS next Q-0.23 Inst Own19.80% Short Float30.32% Perf Quarter-13.91%
Sales11.70M P/S27.26 EPS this Y-182.50% Inst Trans60.41% Short Ratio8.19 Perf Half Y15.56%
Book/sh-1.84 P/B- EPS next Y14.10% ROA-153.60% Target Price7.00 Perf Year25.60%
Cash/sh0.36 P/C7.27 EPS next 5Y26.80% ROE53.00% 52W Range0.67 - 6.96 Perf YTD12.07%
Dividend- P/FCF- EPS past 5Y24.80% ROI189.70% 52W High-62.64% Beta2.80
Dividend %- Quick Ratio0.60 Sales past 5Y220.00% Gross Margin-46.70% 52W Low290.27% ATR0.19
Employees250 Current Ratio0.70 Sales Q/Q-63.70% Oper. Margin- RSI (14)43.99 Volatility4.77% 7.23%
OptionableYes Debt/Eq- EPS Q/Q-149.90% Profit Margin- Rel Volume0.27 Prev Close2.62
ShortableYes LT Debt/Eq- EarningsFeb 27 AMC Payout- Avg Volume4.07M Price2.60
Recom3.00 SMA20-8.84% SMA50-4.74% SMA2006.53% Volume1,096,699 Change-0.76%
Feb-28-18Downgrade Maxim Group Hold → Sell $1
Nov-01-17Downgrade Maxim Group Buy → Hold
Oct-10-17Initiated H.C. Wainwright Buy $7
Oct-06-17Reiterated Maxim Group Buy $4 → $7
Aug-11-17Initiated Maxim Group Buy $4
May-10-16Reiterated RBC Capital Mkts Underperform $0.15 → $0.20
May-10-16Reiterated Piper Jaffray Underweight $0.05 → $0.10
Jan-06-16Reiterated RBC Capital Mkts Underperform $1 → $0.15
Jan-06-16Reiterated Piper Jaffray Underweight $1.50 → $0.05
Nov-04-15Downgrade RBC Capital Mkts Outperform → Underperform $9 → $1
Sep-09-15Downgrade Piper Jaffray Neutral → Underweight
Aug-03-15Reiterated RBC Capital Mkts Outperform $10 → $9
May-11-15Reiterated MLV & Co Hold $7 → $4
May-11-15Downgrade JP Morgan Neutral → Underweight
Apr-16-15Reiterated RBC Capital Mkts Outperform $13 → $10
Aug-12-14Reiterated RBC Capital Mkts Outperform $16 → $13
Jul-01-14Downgrade MLV & Co Buy → Hold $11
Jun-30-14Reiterated Brinson Patrick Market Outperform $12 → $15
Jun-13-14Initiated RBC Capital Mkts Outperform $16
Apr-02-14Reiterated MLV & Co Buy $9 → $11
Mar-16-18 08:41AM  Options Traders Expect Huge Moves in MannKind (MNKD) Stock Zacks
Mar-14-18 08:00AM  MannKind Corporation to Present at Oppenheimer 28th Annual Healthcare Conference GlobeNewswire
Mar-13-18 08:00AM  MannKind Announces STAT Study Results Accepted for Presentation at American Diabetes Associations 78th Scientific Sessions GlobeNewswire
Mar-12-18 08:08AM  MannKind Restructures $79.7 Million Debt Obligation to the Mann Group and Reduces Principal Owed to Deerfield by $6.3 Million GlobeNewswire
Mar-09-18 07:50AM  Research Report Identifies Neogen, AgroFresh Solutions, Ocean Rig UDW, Superior Energy Services, root9B Holdings, and MannKind with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Mar-08-18 01:00PM  Could MannKind Corporation Be a Millionaire-Maker Stock? Motley Fool
Mar-01-18 05:41PM  How Four Managers Outperformed In A Volatile Down Month Forbes
04:01PM  MannKind Opens Enrollment of Phase 1 Trial of Treprostinil Technosphere for Pulmonary Arterial Hypertension GlobeNewswire
Feb-28-18 09:18AM  3 Bright Spots in MannKind Corporation's Q4 Update Motley Fool -7.28%
Feb-27-18 05:37PM  MannKind reports 4Q loss Associated Press
04:01PM  MannKind Corporation Reports 2017 Fourth Quarter and Full Year Financial Results GlobeNewswire
Feb-23-18 08:00AM  MannKind Corporation to Hold 2017 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2018 GlobeNewswire
Feb-13-18 08:30AM  Todays Research Reports on Trending Tickers: Dare Bioscience and MannKind ACCESSWIRE +10.62%
Feb-06-18 08:35AM  MannKind Corporation Appoints Dr. David Kendall as Chief Medical Officer SmarterAnalyst
08:00AM  David Kendall Joins MannKind as Chief Medical Officer GlobeNewswire
Jan-29-18 04:52PM  Here's Why MannKind Briefly Spiked Today Motley Fool
Jan-26-18 01:13PM  Nate Pile Sells Some Nvidia, Buys More MannKind, Apple, And Celgene Forbes -26.58%
12:09PM  Why MannKind Corporation Stock Is Falling Back to Earth Today Motley Fool
08:20AM  Todays Research Reports on Trending Tickers: MannKind Corporation and Pacific Biosciences of California ACCESSWIRE
Jan-25-18 01:40PM  The Most Likely Reason Why MannKind Corporation Skyrocketed Higher Today Motley Fool +41.26%
Jan-21-18 08:33AM  3 Fastest-Growing Diabetes Stocks of 2018 -- According to Wall Street Motley Fool
Jan-18-18 10:00AM  The Simple Reason Why I Won't Buy MannKind Corporation Stock Motley Fool
Jan-16-18 09:00AM  MannKind Corporation to Present at NobleCon14 - Noble Capital Markets Fourteenth Annual Investor Conference GlobeNewswire
Jan-10-18 01:36PM  Bet Against Synergy Pharmaceuticals Inc Stock Has Paid off for Now InvestorPlace
Jan-05-18 09:45AM  These Two Updates Caused MannKind's Stock to Plunge 25.9% in December Motley Fool
07:37AM  How Did Novo Nordisks Modern Insulin Segment Perform in 3Q17? Market Realist
Jan-02-18 05:17PM  Why MannKind Corporation Jumped Higher Today Motley Fool +14.66%
Dec-27-17 05:55AM  [$$] MannKind CEO, Exec Bought Stock in December
Dec-26-17 08:32AM  Do Options Traders Know Something About MannKind Corp (MNKD) Stock We Don't? Zacks
Dec-25-17 12:09PM  ETFs with exposure to MannKind Corp. : December 25, 2017 Capital Cube
Dec-20-17 04:30PM  Why Red Hat, MannKind, and Navistar International Slumped Today Motley Fool -10.94%
Dec-18-17 03:46PM  Why MannKind Corporation Stock Is Sinking Today Motley Fool
Dec-14-17 01:51PM  ETFs with exposure to MannKind Corp. : December 14, 2017 Capital Cube
Dec-05-17 10:34AM  Why MannKind Corporation Dipped 4.8% in November Motley Fool
Nov-30-17 11:02AM  Penny Stocks to Watch for December 2017 Investopedia
Nov-29-17 07:40AM  Report: Exploring Fundamental Drivers Behind Microsoft, Equinix, Fitbit, INC Research, Progressive, and MannKind New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Nov-27-17 02:48PM  ETFs with exposure to MannKind Corp. : November 27, 2017 Capital Cube
10:35AM  Quant Billionaire David Shaw Beats the Drum for Valeant Pharmaceuticals International, Inc. (VRX) and MannKind Corporation (MNKD) SmarterAnalyst
09:00AM  Implied Volatility Surging for MannKind (MNKD) Stock Options Zacks
Nov-22-17 08:20AM  Todays Research Reports on Trending Tickers: MannKind Corporation and TG Therapeutics ACCESSWIRE
Nov-21-17 08:49AM  MannKind Corp. :MNKD-US: Earnings Analysis: Q3, 2017 By the Numbers : November 21, 2017 Capital Cube
06:03AM  MannKind CEO Michael Castagna on What's Ahead for the Biotech Motley Fool
Nov-19-17 08:18AM  An Interview With MannKind CEO Michael Castagna Motley Fool
Nov-15-17 01:10PM  MannKind Corp. Value Analysis (NASDAQ:MNKD) : November 15, 2017 Capital Cube
Nov-14-17 10:25AM  MannKind Corp. breached its 50 day moving average in a Bearish Manner : MNKD-US : November 14, 2017 Capital Cube
Nov-10-17 12:29PM  MannKind Has Much Room for Upside in Diabetes Market: Heres Why SmarterAnalyst
Nov-09-17 10:38AM  Does MannKind Have Enough Funds to Support the Afrezza Launch? 3Q Earnings Disaster Leaves Questions SmarterAnalyst +8.67%
Nov-08-17 08:09PM  5 Things You Don't Want to Overlook in MannKind Corporation's Q3 Update Motley Fool -7.69%
12:53PM  Here's Why MannKind Corporation Is Sinking Motley Fool
Nov-07-17 10:08PM  Edited Transcript of MNKD earnings conference call or presentation 7-Nov-17 10:00pm GMT Thomson Reuters StreetEvents
04:11PM  MannKind reports 3Q loss Associated Press
04:01PM  MannKind Corporation Reports 2017 Third Quarter Financial Results GlobeNewswire
03:00PM  MannKind Corporation to Host Earnings Call ACCESSWIRE
Nov-06-17 01:00PM  Why MannKind Corporation Stock Vaulted Higher in October Motley Fool
07:30AM  Unknown BTCY May Have Big Upside Ahead of Likely Near-Term FDA Approval ACCESSWIRE
Nov-03-17 08:11AM  MannKind Corp. breached its 50 day moving average in a Bullish Manner : MNKD-US : November 3, 2017 Capital Cube
Nov-02-17 01:22PM  [$$] MannKind's Cash Runway Looks Too Short +7.31%
Oct-27-17 09:00AM  MannKind Corporation to Hold 2017 Third Quarter Financial Results Conference Call on November 7, 2017 GlobeNewswire
Oct-25-17 08:00AM  Today's Research Reports on Trending Tickers: MannKind and Opko Health ACCESSWIRE -5.54%
Oct-23-17 09:35AM  MannKind Corporation (MNKD) and BIOMM Advance Afrezza in Brazil SmarterAnalyst -9.98%
08:00AM  MannKind Restructures Near-Term Debt Obligations GlobeNewswire
07:00AM  MannKind and BIOMM Submit Registration Dossier to Brazilian Health Regulatory Agency (ANVISA) GlobeNewswire
Oct-19-17 07:30AM  3 Small-Cap Biotech Stocks That Could Be Big Winners in 2018 Motley Fool
Oct-17-17 04:50PM  Why VirnetX Holding, Badger Meter, and MannKind Slumped Today Motley Fool -12.36%
03:33PM  Is MannKind's Debt a Ticking Time Bomb? Motley Fool
01:55PM  Applied Optoelectronics, Helios And Matheson Among The Top Stocks With Short Sellers Benzinga
Oct-16-17 08:31AM  MannKind, New Labeling Approved by FDA, Recent Analysts Price Targets ACCESSWIRE
Oct-13-17 08:38AM  Options Traders Expect Huge Moves in MannKind (MNKD) Stock Zacks
Oct-12-17 09:00AM  MannKind Donates Afrezza® to Support People with Diabetes Impacted by Hurricane Maria in Puerto Rico GlobeNewswire
08:10AM  Today's Research Reports on Stocks to Watch: MannKind Corporation and Bluebird Bio ACCESSWIRE
06:18AM  Should You Buy the Dip With MannKind Stock? Motley Fool
06:04AM  7 Essential Rules for Investing in Biotech Stocks Motley Fool
Oct-11-17 05:09PM  Why Rite Aid, MannKind, and Sears Holdings Slumped Today Motley Fool -18.48%
01:14PM  Why MannKind Corporation Dropped a Day After It Ran Up Motley Fool
12:05PM  Is MannKind Corp Finally a Buy? Motley Fool
09:17AM  MannKind's stock tumbles after share offering, in wake of recent tripling in price MarketWatch
12:02AM  MannKind Announces $61 Million Registered Direct Offering of Common Stock GlobeNewswire
Oct-10-17 04:30PM  Why MannKind, Nutanix, and Smith & Nephew Jumped Today Motley Fool +25.89%
03:15PM  MannKind Tripled In The Past 3 Weeks; Vindicating Nate Pile Forbes
12:00PM  Why MannKind Corporation Stock Is Jumping Today Motley Fool
09:52AM  This top investment newsletter is winning big on one stock MarketWatch
06:49AM  [$$] MannKind Stock Seen Reaching $7
Oct-07-17 10:34AM  3 Drug Stocks That Soared This Week: Are They Buys? Motley Fool
Oct-06-17 11:30PM  [$$] Charting the Market
09:20AM  Fridays Vital Data: MannKind Corporation (MNKD), Apple Inc. (AAPL) and Netflix, Inc. (NFLX) InvestorPlace
Oct-05-17 05:04PM  Is MannKind Corporation Stock Still a Strong Buy? Motley Fool +40.11%
02:24PM  MannKind's stock rockets on heavy volume for third-straight session MarketWatch
11:18AM  3 Tech Stocks Investors Are Watching ACCESSWIRE
Oct-04-17 06:26PM  Should You Be Tempted To Buy MannKind Corporation (MNKD) Because Of Its PE Ratio? Simply Wall St. +25.53%
04:30PM  Why MannKind, Intelsat, and Benefitfocus Jumped Today Motley Fool
01:49PM  [$$] MannKind Victorious in Label Revision
08:10AM  Today's Research Reports on Stocks to Watch: Mannkind and EnteroMedics ACCESSWIRE
07:00AM  Corporate News Blog - MannKind Announces Afrezza Updates from FDA; Includes New Data on Rapid Onset of Activity and Effect Duration ACCESSWIRE
Oct-03-17 08:49AM  MannKind (MNKD) in Focus: Stock Moves 7.8% Higher Zacks +20.51%
Oct-02-17 04:56PM  Why MannKind Corporation Popped Today Motley Fool +7.83%
03:02PM  Why MannKind Stock Started October With a Bang Motley Fool
09:35AM  3 Biotech Stocks That Are Trending Pre-Market On Monday ACCESSWIRE
06:00AM  FDA Updates Afrezza® Prescribing Information GlobeNewswire
Oct-01-17 05:00PM  MannKind Corporation to Hold Investor Conference Call GlobeNewswire
Sep-29-17 08:00AM  Today's Research Reports on Trending Tickers: MannKind Corporation and Spectrum Pharmaceuticals ACCESSWIRE
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for diabetes and pulmonary arterial hypertension patients. It offers Afrezza, a dry powder formulation of human insulin that controls high blood sugar in adults with type 1 and type 2 diabetes in the United States. The company was founded in 1991 and is headquartered in Westlake Village, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tross Stuart ACorp VP, Chief People OfficerDec 21Buy2.5239,840100,39759,840Dec 21 09:36 PM
Castagna MichaelChief Executive OfficerDec 20Buy2.281,5003,4201,500Dec 20 04:53 PM
Castagna MichaelChief Executive OfficerDec 20Buy2.296,50014,87135,532Dec 20 04:53 PM
KRESA KENTDirectorOct 13Buy6.00166,600999,600237,589Oct 13 05:03 PM
Urbanski Raymond W.Corp VP, CMOAug 10Sale1.152963402,924Aug 11 06:17 PM
Alinaya Rosabel RealicaSVP, Investor RelationsJun 30Buy1.232,0002,46030,091Aug 23 07:10 PM
PFEFFER MATTHEW JDirectorJun 30Buy1.232,0002,46082,617Aug 23 07:07 PM